Position in AXGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$12,751,737
-$2,628,090 QoQ
Shares Held
384,900
-18.1% QoQ
Ownership
0.724%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $143,832,785 across 15 Medical Devices names. AXGN ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
678,172 | $42,555,293 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
359,492 | $25,588,640 | |
| 3 | ABT |
Abbott Laboratories
|
210,484 | $21,610,392 | |
| 4 | MDT |
Medtronic plc
|
170,833 | $14,802,679 | |
| 5 | AXGN |
Axogen, Inc.
This page
|
384,900 | $12,751,737 | |
| 6 | SNN |
Smith & Nephew PLC
|
208,997 | $6,641,924 | |
| 7 | EW |
Edwards Lifesciences Corp
|
61,115 | $4,894,089 | |
| 8 | VMD |
Viemed Healthcare, Inc.
|
472,100 | $4,348,041 |
All Filings in AXGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,751,737 | 384,900 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $15,379,827 | 469,900 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,650,616 | 484,900 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,261,165 | 484,900 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,970,650 | 484,900 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $9,721,552 | 589,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,742,498 | 694,900 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,574,076 | 769,900 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,213,093 | 769,900 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,258,417 | 769,900 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,674,500 | 934,900 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,294,752 | 470,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,016,250 | 425,000 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,241,500 | 425,000 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,291,200 | 360,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,948,400 | 360,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,659,900 | 335,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,717,300 | 290,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,817,000 | 115,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,485,150 | 115,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,329,900 | 115,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,058,500 | 115,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,337,450 | 115,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,062,600 | 115,000 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||